We found that, as in the case of breast cancer, hybrid E/M cell lines exhibit significantly higher levels of PD-L1 than epithelial ones, but there was not a significant difference between hybrid E/M and mesenchymal cell lines (Figure 5A). The gene discussed is CD274; the disease is breast carcinoma.